We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00152425
Recruitment Status : Completed
First Posted : September 9, 2005
Last Update Posted : September 9, 2013
Information provided by:
UCB Pharma

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : May 2005
  Study Completion Date : May 2005

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):